Literature DB >> 34993063

Diffusion-weighted imaging of breast invasive lobular carcinoma: comparison with invasive carcinoma of no special type using a histogram analysis.

Seongkyun Jeong1, Tae Hee Kim2.   

Abstract

BACKGROUND: To investigate the imaging findings and visibility of breast invasive lobular carcinoma (ILC) on diffusion-weighted imaging (DWI) and compare quantitative apparent diffusion coefficient (ADC) metrics of ILC and invasive carcinoma of no special type (NST) using a histogram analysis.
METHODS: We performed an observational retrospective study of 629 consecutive women with pathologically proven ILC and invasive ductal carcinoma of NST, who underwent 3-T MRI including DWI, between January 2017 and August 2020.
RESULTS: After propensity score matching, 71 women were allocated to each group. On DWI, 9 (12.7%) lesions of ILC and 4 (5.6%) invasive carcinomas of the NST were not visualized. For the tumor visibility on DWI, tumor size, tumor ADC value, and background diffusion grade were significantly associated with the visibility score in both groups (all P<0.05), whereas the mean background ADC value was not significant (P>0.05). The mean ADC (1.226×10-3 vs. 1.052×10-3 mm2/s, P<0.001), median ADC (1.222×10-3 vs. 1.051×10-3 mm2/s, P=0.002), maximum ADC (1.758×10-3 vs. 1.504×10-3 mm2/s, P<0.001), minimum ADC (0.717×10-3 vs. 0.649×10-3 mm2/s, P=0.003), 90th percentile ADC (1.506×10-3 vs. 1.292×10-3 mm2/s, P<0.001) and 10th percentile ADC (0.956×10-3 vs. 0.818×10-3 mm2/s, P=0.008) were higher in ILC than in invasive carcinoma of NST. Additionally, the ADC difference value of the ILC was higher than that of invasive carcinoma of NST (1.04×10-3 vs. 0.855×10-3 mm2/s, P=0.027).
CONCLUSIONS: On DWI, the visibility of ILC was lower compared to invasive carcinoma of NST. ILC showed higher quantitative ADC values and higher ADC difference values. 2022 Quantitative Imaging in Medicine and Surgery. All rights reserved.

Entities:  

Keywords:  Diffusion-weighed imaging (DWI); apparent diffusion coefficient (ADC); invasive lobular carcinoma (ILC); prognostic

Year:  2022        PMID: 34993063      PMCID: PMC8666783          DOI: 10.21037/qims-21-355

Source DB:  PubMed          Journal:  Quant Imaging Med Surg        ISSN: 2223-4306


  34 in total

1.  Unenhanced breast MRI (STIR, T2-weighted TSE, DWIBS): An accurate and alternative strategy for detecting and differentiating breast lesions.

Authors:  Michele Telegrafo; Leonarda Rella; Amato Antonio Stabile Ianora; Giuseppe Angelelli; Marco Moschetta
Journal:  Magn Reson Imaging       Date:  2015-06-25       Impact factor: 2.546

2.  Diffusion-weighted imaging in assessing pathological response of tumor in breast cancer subtype to neoadjuvant chemotherapy.

Authors:  Shangang Liu; Ruimei Ren; Zhaoqiu Chen; Yongsheng Wang; Tingyong Fan; Chengli Li; Pinliang Zhang
Journal:  J Magn Reson Imaging       Date:  2015-01-08       Impact factor: 4.813

Review 3.  Effect of b value and pre-admission of contrast on diagnostic accuracy of 1.5-T breast DWI: a systematic review and meta-analysis.

Authors:  Monique D Dorrius; Hildebrand Dijkstra; Matthijs Oudkerk; Paul E Sijens
Journal:  Eur Radiol       Date:  2014-08-09       Impact factor: 5.315

4.  Breast cancer detection using double reading of unenhanced MRI including T1-weighted, T2-weighted STIR, and diffusion-weighted imaging: a proof of concept study.

Authors:  Rubina M Trimboli; Nicola Verardi; Francesco Cartia; Luca A Carbonaro; Francesco Sardanelli
Journal:  AJR Am J Roentgenol       Date:  2014-09       Impact factor: 3.959

5.  Correlations between diffusion-weighted imaging and breast cancer biomarkers.

Authors:  Laura Martincich; Veronica Deantoni; Ilaria Bertotto; Stefania Redana; Franziska Kubatzki; Ivana Sarotto; Valentina Rossi; Michele Liotti; Riccardo Ponzone; Massimo Aglietta; Daniele Regge; Filippo Montemurro
Journal:  Eur Radiol       Date:  2012-03-13       Impact factor: 5.315

6.  ADC mapping of benign and malignant breast tumors.

Authors:  Reiko Woodhams; Keiji Matsunaga; Shinichi Kan; Hirofumi Hata; Masanori Ozaki; Keiichi Iwabuchi; Masaru Kuranami; Masahiko Watanabe; Kazushige Hayakawa
Journal:  Magn Reson Med Sci       Date:  2005       Impact factor: 2.471

7.  Diffusion-weighted Imaging of Invasive Breast Cancer: Relationship to Distant Metastasis-free Survival.

Authors:  Jin You Kim; Jin Joo Kim; Lee Hwangbo; Taewoo Kang; Heeseung Park
Journal:  Radiology       Date:  2019-03-12       Impact factor: 11.105

8.  Diagnostic accuracy of mammography, clinical examination, US, and MR imaging in preoperative assessment of breast cancer.

Authors:  Wendie A Berg; Lorena Gutierrez; Moriel S NessAiver; W Bradford Carter; Mythreyi Bhargavan; Rebecca S Lewis; Olga B Ioffe
Journal:  Radiology       Date:  2004-10-14       Impact factor: 11.105

9.  MRI-only lesions: application of diffusion-weighted imaging obviates unnecessary MR-guided breast biopsies.

Authors:  Claudio Spick; Katja Pinker-Domenig; Margaretha Rudas; Thomas H Helbich; Pascal A Baltzer
Journal:  Eur Radiol       Date:  2014-04-05       Impact factor: 5.315

10.  Analysis of factors influencing the degree of detectability on diffusion-weighted MRI and diffusion background signals in patients with invasive breast cancer.

Authors:  Soo Yeon Hahn; Eun Sook Ko; Boo-Kyung Han; Yaeji Lim; Seonhye Gu; Eun Young Ko
Journal:  Medicine (Baltimore)       Date:  2016-07       Impact factor: 1.889

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.